These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8447164)

  • 1. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
    Sinha VB; Jacob A; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):372-5. PubMed ID: 8447164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Jacob A; Sinha VB; Sahib MK; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):376-82. PubMed ID: 8447165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.
    Richardson K
    Infect Immun; 1991 Aug; 59(8):2727-36. PubMed ID: 1855990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane.
    Richardson K; Parker CD
    Infect Immun; 1985 Mar; 47(3):674-9. PubMed ID: 3972446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine.
    Chandrasekhar U; Sinha S; Bhagat HR; Sinha VB; Srivastava BS
    Vaccine; 1994 Nov; 12(15):1384-8. PubMed ID: 7887015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossed immunoelectrophoretic analysis of antigenic composition of B-subunit/whole-cell and whole-cell only killed oral cholera vaccines.
    Ciznár I; Ahsan CR; Rahman A; Shahabuddin M; Bartková G; Clemens JD; Sack DA
    Vaccine; 1992; 10(9):591-6. PubMed ID: 1502836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.
    Silva AJ; Leitch GJ; Camilli A; Benitez JA
    Infect Immun; 2006 Apr; 74(4):2072-9. PubMed ID: 16552036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
    Cryz SJ; Fürer E; Germanier R
    Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flagella-induced immunity against experimental cholera in adult rabbits.
    Yancey RJ; Willis DL; Berry LJ
    Infect Immun; 1979 Jul; 25(1):220-8. PubMed ID: 478635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification and identification of pili of Vibrio cholera O139].
    Du Y; Jia W; Liu C
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Mar; 30(1):28-30. PubMed ID: 12205915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
    Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
    FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
    Sharma DP; Thomas C; Hall RH; Levine MM; Attridge SR
    Vaccine; 1989 Oct; 7(5):451-6. PubMed ID: 2573216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies to toxin-coregulated pili in sera from cholera patients.
    Attridge SR; Wallerström G; Qadri F; Svennerholm AM
    Infect Immun; 2004 Mar; 72(3):1824-7. PubMed ID: 14977996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new vaccinating antigenic fraction obtained from "Vibrio cholerae" I.--Isolation and characterization of the new fraction (author's transl)].
    Dodin A; Wiart J
    Ann Microbiol (Paris); 1975 Jan; 126(1):39-44. PubMed ID: 811146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae.
    Attridge SR; Rowley D
    J Infect Dis; 1983 Nov; 148(5):931-9. PubMed ID: 6195273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios.
    Sengupta DK; Sengupta TK; Ghose AC
    FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.